FHA
ADVM

Flagship Harbor Advisors’s Adverum Biotechnologies ADVM Stock Holding History

Flagship Harbor Advisors’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20
Closed -$2K – 580
2020
Q3 		$2K Hold
20
– – ﹤0.01% 1697
2020
Q2 		$4K Hold
20
– – ﹤0.01% 1622
2020
Q1 		$2K Hold
20
– – ﹤0.01% 1608
2019
Q4 		$2K Hold
20
– – ﹤0.01% 1688
2019
Q3 		$1K Hold
20
– – ﹤0.01% 1726
2019
Q2 		$2K Hold
20
– – ﹤0.01% 1657
2019
Q1 		$1K Hold
20
– – ﹤0.01% 1731
2018
Q4 		$0 Hold
20
– – ﹤0.01% 1819
2018
Q3 		$1K Hold
20
– – ﹤0.01% 1961
2018
Q2 		$1K Buy
+20
New +$1.2K ﹤0.01% 1912

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Flagship Harbor Advisors's ADVM Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Adverum Biotechnologies (ADVM) in Q4 2020, closing a stake of 20 shares — an estimated $2K sold.

Flagship Harbor Advisors first reported a position in ADVM in Q2 2018 and held it in 10 quarters. The position peaked at $4K in Q2 2020. 155 funds tracked by Wall St. Rank hold ADVM as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Adverum Biotechnologies position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 20 Adverum Biotechnologies shares in Q4 2020, an estimated $2K.
  • Flagship Harbor Advisors first reported a position in Adverum Biotechnologies in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Adverum Biotechnologies position peaked at $4K in Q2 2020.
  • 155 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.